Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Ukraine location entry was updated from Zaporizhzhia to Zaporizhzhya, with the same postal code, reflecting corrected transliteration. The page revision was updated from v3.6.3 to v3.6.4 to reflect the latest documentation state.
    Difference
    0.0%
    Check dated 2026-07-28T14:51:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Instituto De Neurología Cognitiva - INECO in Capital Federal, Argentina and Unidade Local de Saúde de Braga in Braga, Portugal, bringing the total number of study locations to 190. Hospital de Braga was removed from the location list.
    Difference
    0.2%
    Check dated 2026-06-30T02:36:44.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now indicates recruitment has closed and introduces new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading formatting and the site version have been updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T21:58:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision tag v3.5.5 was added and the previous v3.5.4 tag was removed. This indicates a minor update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-06-08T17:22:15.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new platform release or patch rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-05-18T03:59:22.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.5.2 to v3.5.3. This reflects a site/version metadata refresh rather than a change to the clinical study information presented.
    Difference
    0.0%
    Check dated 2026-04-26T08:22:53.000Z thumbnail image

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.